
MRNA Stock 11.90% Up, Moderna Plans to Begin COVID-19 Vaccine Human Trials This Spring
According to Moderna Chairman Noubar Afeyan, the second phase of human trials of the COVID-19 vaccine might begin this spring. If the testing is successful, the 3rd phase will immediately begin. MRNA stock went up.